Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Taiwan Semiconductor Is Set to Cash in on AI. Here's What a $5,000 Investment Could Be Worth by 2030.fool.com
Taiwan Semiconductor is likely to be one of the best performing AI stocks in the next few years.
Via The Motley Fool · October 25, 2026
Cathie Wood Just Poured Millions Into 2 Nuclear Stocks -- and Neither Was NuScale Powerfool.com
There are numerous nuclear stocks to consider. Ark Invest has its eyes on two in particular.
Via The Motley Fool · October 25, 2026
Is Intel Stock a Buy Right Now?fool.com
Intel's margins are rising, which could drive significant earnings growth.
Via The Motley Fool · October 25, 2026
Lexeo Therapeutics Maps Gene Therapy Milestones, Eyes Key 2027 Readoutmarketbeat.com
Lexeo Therapeutics (NASDAQ:LXEO) outlined upcoming clinical and regulatory milestones for its gene therapy programs in Friedreich’s ataxia cardiomyopathy and PKP2-associated arrhythmogenic cardiomyopathy during the Chardan Healthcare Conference. Chief Financial Officer Lou Tamayo said the clinical-
Via MarketBeat · October 25, 2026
Prediction: A Stock Market Crash Is Coming. Here's What Investors Should Do Based on Warren Buffett's Advice.fool.com
The S&P 500 might be vulnerable to a 20% bear market decline, given the growing number of risks.
Via The Motley Fool · October 25, 2026
Netflix Is Down 51% From Its High. History Suggests This Is What Happens Next.fool.com
Volatility is a recurring theme in this company's story line.
Via The Motley Fool · October 25, 2026
Can Planet Fitness Get Its Growth Back in Shape?marketbeat.com
Planet Fitness shares have slumped amid slowing membership growth and AI-related concerns, but analysts see over 30% upside ahead of third-quarter earnings on Nov. 5.
Via MarketBeat · October 25, 2026
Here's What $10,000 Invested Equally in Nvidia, AMD, and Broadcom Could Be Worth by 2030fool.com
An investment in these three stocks could more than triple in value by 2030.
Via The Motley Fool · October 25, 2026
Social Security's Trump Bump-Driven 2027 COLA Is Historic in 3 Unique Waysfool.com
There’s more to Social Security’s annual cost-of-living adjustment (COLA) than meets the eye.
Via The Motley Fool · October 25, 2026
DRDGOLD’s 2027 Outlook: A Debt-Free Gold Miner With a 200% Dividend Hike and an Expansion on Deckfool.com
This under-the-radar mining stock boasts a Superscore of 78 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 25, 2026
Harmony Gold’s 2027 Outlook: Record $1 Billion in Free Cash Flow and a Dividend That Nearly Quintupledfool.com
This under-the-radar gold mining stock boasts a Superscore of 75 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 25, 2026
Ero Copper's 2027 Outlook: Leverage Down From 2.6x to 0.8x With a 24-Year Growth Project Waiting in the Wingsfool.com
This under-the-radar copper mining stock boasts a Superscore of 84 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 25, 2026
Iamgold’s 2027 Outlook: Côté Just Ran Above Nameplate for the First Time, With a 20-Million-Ounce Mine Plan Weeks Awayfool.com
This under-the-radar gold mining stock boasts a Superscore of 81 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 25, 2026
Allied Gold’s 2027 Outlook: Why an Ethiopian Mine Ramping Toward 300,000 Ounces a Year Could Change Everythingfool.com
This under-the-radar gold mining stock boasts a Superscore of 71 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 25, 2026
Why This Hair Restoration Biotech's Shares Are Soaringfool.com
Veradermics' shares are up nearly 270% since its IPO earlier this year.
Via The Motley Fool · October 25, 2026
History Says This ETF Could Be the Biggest Winner of the Stock Market Sell-Offfool.com
If equity markets tumble, the Vanguard Information Technology ETF should be on investors' shopping lists.
Via The Motley Fool · October 25, 2026
Can GE Vernova's Gas Turbines Make Up for a Collapsing Wind Business?fool.com
It's a red flag investors would rather not see waving, but most of them may not have put this shift in its proper perspective.
Via The Motley Fool · October 25, 2026
3 Defined Outcome ETFs Offering Unique Twists on Buffer Strategiesmarketbeat.com
New defined outcome ETFs QBKV, SBAR, and XX offer varied buffer, income, and leveraged strategies tied to small caps, options income, and the S&P 500, each with distinct costs and risks.
Via MarketBeat · October 25, 2026
Here's What a $10,000 Investment in Palantir Could Be Worth in 10 Yearsfool.com
It's up more than 1,000% over the past three years.
Via The Motley Fool · October 25, 2026
Stock-Split Watch: Is Micron Next?fool.com
A stock split could boost Micron's stock price by lowering the price per share.
Via The Motley Fool · October 25, 2026
With Oil Prices Rising, Bitcoin Remains Stuck Below $85,000. Here's Why I'm Still Buying Bitcoin Right Now.fool.com
If history is any guide, pain at the pump should not result in pain for Bitcoin investors.
Via The Motley Fool · October 25, 2026
Here's What the Average Men's Social Security Benefit Is From Ages 62 to 70fool.com
Men's average Social Security benefits exceed women's at every age, a gap rooted in earnings history and survivor-benefit implications.
Via The Motley Fool · October 25, 2026
Eldorado Gold’s 2027 Outlook: Two New Mines Turning On at Once, With 40% Production Growth Guidedfool.com
This under-the-radar mining stock boasts a Superscore of 80 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Via The Motley Fool · October 25, 2026
Prediction: Here's What $500 Invested in Archer Aviation Will Be Worth in 5 Yearsfool.com
This electric air taxi stock is in recovery mode right now.
Via The Motley Fool · October 25, 2026
Opus Genetics Eyes 2029 Runway as Presbyopia Drop Wins FDA Approvalmarketbeat.com
Opus Genetics (NASDAQ:IRD) outlined commercialization expectations for its newly approved presbyopia eye drop, progress across its inherited retinal disease gene therapy pipeline and its funding strategy during an investor panel featuring Chief Executive Officer Dr. George Magrath and Chief Financia
Via MarketBeat · October 25, 2026